State of Wisconsin Investment Board
PRVB

State of Wisconsin Investment Board’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

State of Wisconsin Investment Board’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-70,466
Closed -$1.7M – 2628
2023
Q1 		$1.7M Sell
70,466
-7,196
-9% -$90.3K 0.01% 1348
2022
Q4 		$821K Buy
77,662
+67,520
+666% +$545K ﹤0.01% 1605
2022
Q3 		$46K Sell
10,142
-2,852
-22% -$13K ﹤0.01% 2580
2022
Q2 		$52K Buy
+12,994
New +$61.6K ﹤0.01% 2690
2021
Q4 		– Sell
-67,100
Closed -$429K – 2241
2021
Q3 		$429K Hold
67,100
– – ﹤0.01% 1734
2021
Q2 		$566K Hold
67,100
– – ﹤0.01% 1653
2021
Q1 		$704K Hold
67,100
– – ﹤0.01% 1470
2020
Q4 		$1.14M Sell
67,100
-900
-1% -$13.5K ﹤0.01% 1294
2020
Q3 		$872K Hold
68,000
– – ﹤0.01% 1321
2020
Q2 		$959K Buy
+68,000
New +$859K ﹤0.01% 1248

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State of Wisconsin Investment Board's PRVB Position: Q2 2023 in Review

State of Wisconsin Investment Board sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 70,466 shares — an estimated $1.7M sold.

State of Wisconsin Investment Board first reported a position in PRVB in Q2 2020 and held it in 10 quarters. The position peaked at $1.7M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • State of Wisconsin Investment Board reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 70,466 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.7M.
  • State of Wisconsin Investment Board first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • State of Wisconsin Investment Board's Provention Bio, Inc. Common Stock position peaked at $1.7M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2023, filed 14 Aug 2023.